Nature Medicine Review Time

The translational bridge requirement

Nature Medicine editors are looking for papers that connect basic discovery to clinical application. The editorial question is: does this result move understanding of disease in a way that could eventually change treatment?

"Eventually" is important. The journal doesn't require clinical trials. But it requires that the translational path is plausible, not speculative. A paper about a molecular mechanism is fine if the disease relevance is clear. A paper about a clinical observation is fine if the mechanistic insight is real.

Papers that are purely basic science (no disease connection) belong at Nature or Cell. Papers that are purely clinical (no mechanistic insight) belong at the Lancet or NEJM.

Reviewer expertise matching is harder

Nature Medicine papers need reviewers who understand both the basic science and the clinical context. This is a smaller pool than either pure basic or pure clinical reviewers, which means reviewer recruitment takes longer.

The dual-audience test

Every Nature Medicine paper must work for two audiences: basic scientists who care about the mechanism and clinician-scientists who care about the disease application. The review process tests both angles. A paper that impresses basic reviewers but leaves clinical reviewers unconvinced (or vice versa) faces a harder editorial decision.

Fast desk rejection (1-2 weeks): The translational bridge is missing. The paper is either too basic (no disease relevance) or too clinical (no mechanistic insight). Most common outcome.

Slow desk decision (3-4 weeks): The editor is considering whether the translational angle is strong enough. This can be a positive sign.

Review taking 10+ weeks: Normal. Finding dual-expertise reviewers is hard. The journal may be waiting for a clinical reviewer to respond.

Major revision requesting human data: Common for papers with strong animal model data but no human validation. Nature Medicine increasingly expects some human relevance evidence.

Submit if:

• the paper connects a mechanistic discovery to disease understanding or treatment
• you have evidence from both basic and translational/clinical models
• the finding could change how the field thinks about a disease mechanism
• the translational path is plausible, even if distant from clinical application

Think twice if:

• the paper is purely mechanistic without disease relevance (Nature or Cell is better)
• the paper is purely clinical without mechanistic insight (Lancet or NEJM is better)
• the human data supporting the translational bridge is absent
• Science Translational Medicine might be a better fit for the scope

A free manuscript scan can help assess whether the translational framing is strong enough for Nature Medicine before submission.

How long does Nature Medicine take to desk-reject?

Typically 1-2 weeks. Over 70% of submissions are desk-rejected.

How long does Nature Medicine peer review take?

5-8 weeks for reviewer reports, 8-14 weeks total to first decision.

Does Nature Medicine require human data?

Not always, but increasingly yes. Animal model data alone is becoming harder to publish without some human validation or relevance evidence.

What's the difference between Nature Medicine and Science Translational Medicine?

Nature Medicine has a higher IF (50.0 vs ~18) and stricter selectivity. Science Translational Medicine accepts a broader range of translational work.